Retrospective Study of the Effects of Cyclosporine in Comparison With Azathioprine on Renal Transplant Recipients Infected With Hepatitis C Virus

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3451-3453

  Ichikawa, Y ^a   Kishikawa, H ^a   Nishimura, K ^a   Tokugawa, S ^a   Yoshioka, I ^a   Arichi, N ^a   Fujii, N ^a   Kyo, M ^a   Nishikawa, M ^a  

^a Hyogo Prefectural Nishinomiya Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY GRAFT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PEPTIC ULCER; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; VASCULAR DISEASE; VIRUS CARRIER;

ADULT; AZATHIOPRINE; CADAVER; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS;

EID: 33845521853     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.134     Document Type: Article

References (7)

1. Hanafusa T., Ichikawa Y., Kishikawa H., et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 66 (1998) 471
2. McHutchison J.G., Gordon S.C., Schiff E.R., et al. Interferon-alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339 (1998) 1485
3. Gane E., and Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 74 (2002) 427
4. Watashi K., Ishii N., Hijikata M., et al. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol Cell 19 (2005) 111
5. Inoue K., Sekiyama K., Yamada M., et al. Combined interferon-α2b and cyclosporine A in the treatment of chronic hepatitis C: controlled trial. Gastroenterology 38 (2003) 567
6. Batty S.D., Swanson J.S., Kirk A.D., et al. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant 1 (2001) 179
7. Pollard S. Calcineurin inhibition and disease recurrence in the hepatitis C virus-positive liver transplant recipient. Liver Int 24 (2004) 402